Fig. 1 · Structure
Documents & Downloads
Oxfenicine
CTP-1 Inhibitor
Oxfenicine is a potent inhibitor of carnitine palmitoyltransferase-1 (CPT-1), a key enzyme in fatty acid metabolism. It effectively reduces fatty acid oxidation in cardiac tissue, providing protection against ischemic necrotic injury and reducing cardiac apoptosis. Additionally, Oxfenicine enhances lipolysis in models of high-fat diet, making it a valuable tool for investigating cardiovascular and metabolic diseases. Its diverse biological activity supports its application in preclinical research related to heart and metabolic health.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 32462-30-9 |
| Applications | CTP-1 Inhibitor |
| Formula | C8H9NO3 |
| Molecular Weight | 167.16 |
| Synonyms | L-p-Hydroxyphenylglycine; 4-Hydroxy-L-phenylglycine; UK 25842 |
| SMILES | O=C([C@H](C1=CC=C(C=C1)O)N)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.